3Mandelin E, Koistinen H, Koistinen R, et al. Levonorgestrel- releasing intrauterine device-wearing women express contraceptive glycodelin A in endometrium during midcycle: another contraceptive mechanism? Hum Reprod, 1997, 12: 2671-2675.
4Barbosa I, Bakos O, Olsson SE, et al. Ovarian function during use of a levonorgestrel-releasing IUD. Contraception, 1990, 42 : 51-66.
5Silverberg SG, Haukkamaa M, Arko H, et al. Endometrial morphology during long-term use of levonorgestrel intrauterine devices. Int J Gynecol Pathol, 1986, 5:235-241.
6WHO. Intrauterine devices: technical and managerial guidelines for services. Geneva: WHO Publication, 1997:7-8.
7Andersson K, Odlind V, Rybo G. Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception, 1994, 49:56-72.
8Brrington JW, Bowen-Simikins P. The levonorgestrel intrauterine system in the management of menorrhagia. Br J Obstet Gynaecol, 1997, 104:614-616.
9Xiao B, Zeng T, Wu S, et al. Effect of levonorgestreI-releasing intrauterine device on hormonal profile and menstrual pattern after long-term use. Contraception, 1995, 51: 359-365.
10Luukkainen T, Lahteenmaki P, Toivonen J. Levonorgestrel- releasing intrauterine device. Ann Med, 1990,22: 85-90.
